Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.
It’s the art of the deal meets the art of trade war,’ Charles Payne said during his Fox Business show on Thursday afternoon ...